Frequently Asked Questions About Non-Insulin Injectables
1. Q: What are non-insulin injectable treatments for diabetes?
A: There are two classes of drugs that are approved by the Federal Drug Administration (FDA) for type 2 diabetes that are considered non-insulin injectables: Glucagon-like peptide 1 (GLP-1) receptor agonists and amylin analogs. GLP-1 receptor agonists work by mimicking that activity of the naturally-occurring GLP-1 hormone, which stimulates the production of insulin.
Amylin analogs mimic the behavior of another hormone that’s essential in controlling blood sugar levels: amylin. Amylin, like insulin, is released by your pancreas after you eat. People with type 2 diabetes tend to have lower levels of amylin, so amylin analogs are meant to act as the missing hormone – lowering blood sugar, slowing the speed at which food empties from the stomach, and as an added benefit, suppressing appetite.
2. Q: What is GLP-1 therapy for diabetes?
A: Glucagon-like peptide 1 (GLP-1) based diabetes therapy is a type of injectable treatment used by people with type 2 diabetes to stimulate the secretion of insulin, the hormone that keeps your blood sugar from getting too high. While insulin injections replace the insulin your pancreas fails to make, GLP-1 stimulates insulin production if you’re someone who has trouble producing enough of it to keep their blood sugar in check.
Humans naturally produce the GLP-1 hormone in the small intestine. After we eat, the intestine signals the pancreas to make more insulin. GLP-1 likely doesn’t have much of an effect on the average person because it’s degraded, or broken down within two minutes in the human body. But when the GLP-1 hormone is modified so that it doesn’t degrade, as it is with GLP-1 based therapies, it lasts for hours, and becomes a very powerful stimulus of insulin secretion.
Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced
or reprinted without permission from Healthgrades Operating Company, Inc. Use
of this information is governed by the Healthgrades User Agreement.